AB
Healthcare & Life Sciences
Angiocrine Bioscience
United States
Angiocrine Bioscience is a Healthcare & Life Sciences startup based in the United States, most recent round Series B.
series-b
series-b
Stage
About Angiocrine Bioscience
Based in the United States, Angiocrine Bioscience is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.
Angiocrine Bioscience is a clinical stage biotechnology company that develops cell therapies targeting endothelial cells to treat hematologic diseases and cancer.
Explore Angiocrine Bioscience's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.